Telehealth Executives Charged in $100M Adderall Fraud Scheme

Federal charges against Done Global executives could disrupt ADHD treatment for tens of thousands of patients.

Federal indictment charges Done Global executives with health care fraud and obstruction of justice.
The scheme allegedly exploited COVID-19 telehealth flexibilities to distribute Adderall without proper diagnosis.
Up to 50,000 ADHD patients may face treatment disruptions due to the company's practices.
CDC warns of increased risks for injury and overdose if patients seek unregulated medication.
The arrests highlight ongoing issues with telehealth regulation and ADHD medication shortages.